Skip to main content
Ch. 15 - Gene Mutation, DNA Repair, and Transposition
Chapter 15, Problem 16

A significant number of mutations in the HBB gene that cause human β-thalassemia occur within introns or in upstream noncoding sequences. Explain why mutations in these regions often lead to severe disease, although they may not directly alter the coding regions of the gene.

Verified step by step guidance
1
span>Step 1: Understand the role of the HBB gene. The HBB gene encodes the beta-globin subunit of hemoglobin, which is crucial for oxygen transport in the blood. Mutations in this gene can disrupt normal hemoglobin function, leading to β-thalassemia.</span
span>Step 2: Recognize the importance of noncoding regions. Although introns and upstream noncoding sequences do not code for proteins, they play critical roles in gene expression regulation, including transcription initiation, RNA splicing, and mRNA stability.</span
span>Step 3: Consider the impact of mutations in introns. Mutations in introns can affect RNA splicing, potentially leading to the inclusion of intronic sequences in the mRNA or the exclusion of exonic sequences, resulting in a dysfunctional protein.</span
span>Step 4: Examine the effect of mutations in upstream noncoding sequences. These regions often contain promoter elements and regulatory sequences that control the timing and level of gene expression. Mutations here can lead to reduced or inappropriate expression of the HBB gene.</span
span>Step 5: Connect the dots. Even though these mutations do not alter the coding sequence directly, they can severely disrupt the production and function of the beta-globin protein, leading to the symptoms of β-thalassemia.</span

Verified video answer for a similar problem:

This video solution was recommended by our tutors as helpful for the problem above.
Video duration:
31s
Was this helpful?

Key Concepts

Here are the essential concepts you must grasp in order to answer the question correctly.

Introns and Noncoding Sequences

Introns are noncoding segments of a gene that are transcribed into precursor mRNA but are removed during RNA splicing. Noncoding sequences upstream of a gene can regulate gene expression. Mutations in these regions can disrupt splicing or regulatory elements, leading to improper gene expression or protein production, which can result in severe diseases like β-thalassemia.
Recommended video:
Guided course
08:41
Sequencing Difficulties

Gene Regulation

Gene regulation involves mechanisms that control the timing, location, and amount of gene expression. Regulatory elements, such as enhancers and silencers, can be located in noncoding regions. Mutations in these areas can alter the binding of transcription factors, leading to insufficient or excessive production of the gene product, contributing to disease pathology.
Recommended video:
Guided course
09:22
Review of Regulation

Splicing Mechanism

Splicing is the process by which introns are removed from precursor mRNA and exons are joined together to form mature mRNA. Mutations affecting splicing signals can lead to the inclusion of introns or exclusion of exons in the final mRNA. This can produce dysfunctional proteins or lead to nonsense-mediated decay, both of which can severely impact cellular function and contribute to conditions like β-thalassemia.
Recommended video:
Guided course
09:22
Review of Regulation
Related Practice
Textbook Question
Contrast the various types of DNA repair mechanisms known to counteract the effects of UV radiation. What is the role of visible light in repairing UV-induced mutations?
467
views
Textbook Question

Refer to Figure 13.7 to respond to the following:

A base-substitution mutation that altered the sequence shown in part (a) eliminated the synthesis of all but one polypeptide. The altered sequence is shown here:

 5'-AUGCAUACCUAUGUGACCCUUGGA-3'

Determine why.

428
views
Textbook Question
The family of a sixth-grade boy in Palo Alto, California, was informed by school administrators that he would have to transfer out of his middle school because they believed his mutation of the CFTR gene, which does not produce any symptoms associated with cystic fibrosis, posed a risk to other students at the school who have cystic fibrosis. After missing 11 days of school, a settlement was reached to have the boy return to school. What ethical problems might you associate with this example?
253
views
Textbook Question

Dominant mutations can be categorized according to whether they increase or decrease the overall activity of a gene or gene product. Although a loss-of-function mutation (a mutation that inactivates the gene product) is usually recessive, for some genes, one dose of the normal gene product, encoded by the normal allele, is not sufficient to produce a normal phenotype. In this case, a loss-of-function mutation in the gene will be dominant, and the gene is said to be haploinsufficient. A second category of dominant mutation is the gain-of-function mutation, which results in a new activity or increased activity or expression of a gene or gene product. The gene therapy technique currently being used in clinical trials involves the 'addition' to somatic cells of a normal copy of a gene. In other words, a normal copy of the gene is inserted into the genome of the mutant somatic cell, but the mutated copy of the gene is not removed or replaced. Will this strategy work for either of the two aforementioned types of dominant mutations?

458
views
Textbook Question
Contrast the structure of SINE and LINE DNA sequences. Why are LINEs referred to as retrotransposons?
562
views
Textbook Question

In 2013 the actress Angelina Jolie elected to have prophylactic double-mastectomy surgery to prevent breast cancer based on a positive test for mutation of the BRCA1 gene. What are some potential positive and negative consequences of this high-profile example of acting on the results of a genetic test?

517
views